Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial.

Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv. 2012 Jun; 5(3):347-56.

View in: PubMed

subject areas

Administration, Oral
Angioplasty, Balloon, Coronary
Canada
Double-Blind Method
Drug Administration Schedule
Europe
Female
Heart Diseases
Humans
Injections, Intravenous
Male
Middle Aged
Models, Statistical
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Function Tests
Purinergic P2Y Receptor Antagonists
Quinazolinones
Receptors, Purinergic P2Y12
Sulfonamides
Ticlopidine
Treatment Outcome
United States

authors with profiles

Robert Harrington